IT8048997A0 - 4-AROILIMIDAZOL-2-ONS EQUIPPED WITH ANTI-HYPERTENSIVE CARDIOTONIC AND ANTITHROMBOTIC PROPERTIES AND PROCEDURE FOR THEIR PREPARATION - Google Patents

4-AROILIMIDAZOL-2-ONS EQUIPPED WITH ANTI-HYPERTENSIVE CARDIOTONIC AND ANTITHROMBOTIC PROPERTIES AND PROCEDURE FOR THEIR PREPARATION

Info

Publication number
IT8048997A0
IT8048997A0 IT8048997A IT4899780A IT8048997A0 IT 8048997 A0 IT8048997 A0 IT 8048997A0 IT 8048997 A IT8048997 A IT 8048997A IT 4899780 A IT4899780 A IT 4899780A IT 8048997 A0 IT8048997 A0 IT 8048997A0
Authority
IT
Italy
Prior art keywords
aroilimidazol
cardiotonic
ons
hypertensive
procedure
Prior art date
Application number
IT8048997A
Other languages
Italian (it)
Other versions
IT1143922B (en
Inventor
Richard A Schnettler
Richard C Dage
Grisar J Martin
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8048997(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of IT8048997A0 publication Critical patent/IT8048997A0/en
Application granted granted Critical
Publication of IT1143922B publication Critical patent/IT1143922B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT48997/80A 1979-06-18 1980-06-17 4-AROILIMIDAZOL-2-ONI EQUIPPED WITH CARDIOTONIC AND ANTI-THROMBOTIC ANTI-HYPERTENSIVE PROPERTIES AND PROCEDURE FOR THEIR PREPARATION IT1143922B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
IT8048997A0 true IT8048997A0 (en) 1980-06-17
IT1143922B IT1143922B (en) 1986-10-29

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48997/80A IT1143922B (en) 1979-06-18 1980-06-17 4-AROILIMIDAZOL-2-ONI EQUIPPED WITH CARDIOTONIC AND ANTI-THROMBOTIC ANTI-HYPERTENSIVE PROPERTIES AND PROCEDURE FOR THEIR PREPARATION

Country Status (20)

Country Link
AT (1) AT375349B (en)
AU (1) AU532783B2 (en)
CA (1) CA1132554A (en)
CH (1) CH646155A5 (en)
DE (1) DE3021792A1 (en)
DK (1) DK160269C (en)
ES (1) ES8105299A1 (en)
FR (1) FR2459233A1 (en)
GB (1) GB2055364B (en)
HK (1) HK61486A (en)
HU (1) HU186736B (en)
IE (1) IE50646B1 (en)
IL (1) IL60243A (en)
IT (1) IT1143922B (en)
MY (1) MY8600709A (en)
NL (2) NL193752C (en)
NO (1) NO152841C (en)
NZ (1) NZ193935A (en)
PH (1) PH18683A (en)
SE (2) SE447107B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329470A (en) 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
ZA822990B (en) * 1981-05-04 1983-03-30 Merrell Dow Pharma 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2005092333A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (en) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Process of preparing guanylate cyclase c agonists.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (en) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc ULTRAPURE GUANYLATE CYCLASE C AGONISTS, METHOD OF MANUFACTURING AND USING THEM
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport
CN114539157B (en) * 2022-03-03 2023-12-22 曲靖师范学院 Method for preparing 4-iodo-N-aryl pyrazole compound by iodine-promoted oxidation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NL8003498A (en) 1980-12-22
HK61486A (en) 1986-08-29
NO152841B (en) 1985-08-19
CA1132554A (en) 1982-09-28
MY8600709A (en) 1986-12-31
DE3021792A1 (en) 1981-01-22
NL193752C (en) 2000-09-04
HU186736B (en) 1985-09-30
ES492255A0 (en) 1981-06-01
CH646155A5 (en) 1984-11-15
IE801162L (en) 1980-12-18
GB2055364A (en) 1981-03-04
IT1143922B (en) 1986-10-29
SE464559B (en) 1991-05-13
DK160269B (en) 1991-02-18
NO801796L (en) 1980-12-19
SE447107B (en) 1986-10-27
SE8004253L (en) 1980-12-19
GB2055364B (en) 1983-06-08
IL60243A (en) 1987-01-30
AU532783B2 (en) 1983-10-13
SE8501452D0 (en) 1985-03-25
NO152841C (en) 1985-11-27
IE50646B1 (en) 1986-06-11
AT375349B (en) 1984-07-25
ES8105299A1 (en) 1981-06-01
NL193752B (en) 2000-05-01
AU5911880A (en) 1981-01-08
DE3021792C2 (en) 1989-08-10
PH18683A (en) 1985-08-29
FR2459233A1 (en) 1981-01-09
ATA314280A (en) 1983-12-15
NL300015I1 (en) 2000-11-01
DK160269C (en) 1991-07-22
FR2459233B1 (en) 1983-09-23
NZ193935A (en) 1985-05-31
DK259080A (en) 1980-12-19
IL60243A0 (en) 1980-09-16
NL300015I2 (en) 2000-10-02
SE8501452L (en) 1985-03-25

Similar Documents

Publication Publication Date Title
IT8048997A0 (en) 4-AROILIMIDAZOL-2-ONS EQUIPPED WITH ANTI-HYPERTENSIVE CARDIOTONIC AND ANTITHROMBOTIC PROPERTIES AND PROCEDURE FOR THEIR PREPARATION
IT1144079B (en) NEW PIPERIDINE DERIVATIVES EQUIPPED WITH ANTI-HISTORIC ANTI-ALLERGIC AND BRONCODILATATORY PROPERTIES AND PROCEDURE FOR THEIR PREPARATION
ES525743A0 (en) PROCEDURE FOR THE MANUFACTURE OF 4'-DEMETIL-EPIPODOFILOTOXIN-B-D-ETILIDEN-GLUCOSIDO AND ACYLIC DERIVATIVE OF THE SAME
IT8048000A0 (en) HETEROCICLIC COMPOUNDS WITH PHARMACOLOGICAL PROPERTIES AND PROCEDURE FOR THEIR PREPARATION
IT1209254B (en) PROCEDURE FOR DETECTING LOSSES IN CONDUCTURES AND EQUIPMENT FOR THE IMPLEMENTATION OF THE PROCEDURE.
IT8148261A0 (en) AMIDES WITH PHARMACEUTICAL PROPERTIES AND THEIR PREPARATION
NO802843L (en) PROCEDURE FOR MANUFACTURING ACTIVE CARBON IN FIBROE'S FORM
IT1171520B (en) PROCEDURE FOR THE PREPARATION OF 2-AMINO-3-CARBETOXYAMINE-6- (P-FLUOR-BENZYLAMINE) -PYRIDIN-EVIL EQUIPPED WITH PHARMACOLOGICAL PROPERTIES AND PRODUCT OBTAINED
GB2066812B (en) 5'-acyl-uridine derivatives and processes for the preparation thereof
IT1162369B (en) 1- (2-ARIL-1,3-DIOSSAN-2-IL-METHYL) -1H-IMIDAZOLS AND 1H-1,2,4-TRIAZOLS EQUIPPED WITH ANTI-MUSHROOM ACTIVITIES AND PROCEDURE FOR THEIR PREPARATION
TR21520A (en) PROCEDURE FOR ALKIL TERT-ALKIL'S COMPOSITION
IT8023649A0 (en) PROCEDURE FOR IMPROVING THE PROPERTIES OF ALLOYS.
TR20746A (en) HOMOSER'S TUEREVES, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MICROBICIDES
IT8083420A0 (en) DERIVATIVES OF AMINO-14 STEROIDS AND PROCEDURE FOR THEIR PREPARATION.
IT1143921B (en) ALCANOIC ACID DERIVATIVES EQUIPPED WITH THERAPEUTIC PROPERTIES AND PROCEDURE FOR THEIR PREPARATION
IT1141392B (en) PROCEDURE FOR THE TRANSFORMATION OF HYDRARGYLITE IN BOEMITE
IT1165040B (en) ALCOSSIALKILIDENIDRAZINOPIRIDAZIONE AND PROCEDURE FOR THEIR PREPARATION
IT1162395B (en) AURONIC DERIVATIVES EQUIPPED WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
IT1174296B (en) SEMIBIOSYNTHETIC TALLISOMYCIN DERIVATIVES EQUIPPED WITH ANTI-MICROBIAL AND ANTI-TUMOR PROPERTIES AND PROCEDURE FOR THEIR PREPARATION
BE879732A (en) ACYL-1H-1,2,4-TRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE
IT8048485A0 (en) ALPHA-HALOGENOMETHYLAMINE DERIVATIVES EQUIPPED WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
IT1145339B (en) ACIDS-6AMINO-SPIRO (PENAM-2,4'-PIPERIDINO) -3-CARBOXYLES AND THEIR PREPARATION PROCEDURE
MC1335A1 (en) DIHYDRONICOTINIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE
GB2058774B (en) 6''-deoxydibekacin-4''6''-dideoxydibe kacin and 1-n-aminoacyl derivatives thereof and their production
IT1148788B (en) DERIVATIVES OF THE AMINOISOKINOLINA AND PROCEDURE FOR THEIR PREPARATION

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 156

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 156, 19920424; MERREL DOW PHARMACEUTICALS INC.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950419